Objectives Systemic inflammation is increasingly being recognised as a possible
mechanism for acute arterial thrombotic events, including acute coronary syndrome (ACS) …

Objectives Systemic inflammation is increasingly being recognised as a possible
mechanism for acute arterial thrombotic events, including acute coronary syndrome (ACS) …

Background There are conflicting data on the risk of acute coronary syndrome (ACS) in
patients with inflammatory bowel disease (IBD). Only a few previous reports include patients …

(1) Background: Inflammatory bowel disease (IBD) induces a process of systemic
inflammation, sharing common ground with acute coronary syndromes (ACS). Growing …

Background Whether patients with inflammatory bowel disease (IBD) exhibit a higher risk of
developing acute coronary syndrome (ACS) remains debatable. Methods From the inpatient …

Background Systemic inflammation and immune-mediated diseases have been associated
with ischemic heart disease in addition to traditional risk factors. In this study, we investigate …

Background The role of inflammation in myocardial infarction (MI) and coronary artery
disease (CAD) progression is now well accepted. Inflammatory bowel diseases (IBD) …

Aims Patients with inflammatory bowel disease (IBD) are known to be at increased risk for
venous thrombosis, while their risk for arterial ischemic events is debated. The purpose of …

Background Patients with chronic inflammatory conditions are at an increased risk of
developing atherothrombotic events. We aimed to assess the 1-year prognosis after …

OBJECTIVES: Patients with inflammatory bowel disease (IBD) present with several
extraintestinal manifestations, including systemic inflammation and hypercoagulability …